Profiling of Copy Number Alterations Using Low-Coverage Whole-Genome Sequencing Informs Differential Diagnosis and Prognosis in Primary Cutaneous Follicle Center Lymphoma
Modern Pathology · 2024-05 · 37 (5) · 100465
DOI: 10.1016/j.modpat.2024.100465 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Pathology, 2024-05. Verfasst von Bence Bátai und 17 weiteren Autor:innen. Beteiligte Einrichtung: HCEMM-SU Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary;…. Hauptthemen laut MEDLINE: Lymphoma, Follicular, Skin Neoplasms, DNA Copy Number Variations, Whole Genome Sequencing. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Semmelweis Egyetem, European Union.
Abstract (Originalsprache)
Primary cutaneous follicle center lymphoma (PCFCL) has an excellent prognosis using local treatment, whereas nodal follicular lymphoma (nFL), occasionally presenting with cutaneous spread, often requires systemic therapy. Distinction of the 2 diseases based on histopathology alone might be challenging. Copy number alterations (CNAs) have scarcely been explored on a genome-wide scale in PCFCL; however, they might serve as potential biomarkers during differential diagnosis and risk stratification. Low-coverage whole-genome sequencing is a robust, high-throughput method for genome-wide copy number profiling. In this study, we analyzed 28 PCFCL samples from 20 patients and compared the copy number profiles with a cohort of diagnostic samples of 64 nFL patients. Although the copy number profile of PCFCL was similar to that of nFL, PCFCL lacked amplifications of 18q, with the frequency peaking at 18q21.33 in nFL cases involving the BCL2 locus (PCFCL: 5.0% vs nFL: 31.3%, P = .018, Fisher exact test). Development of distant cutaneous spread was significantly associated with higher genomic instability including the proportion of genome altered (0.02 vs 0.13, P = .033) and number of CNAs (2 vs 9 P = .017), as well as the enrichment of 2p22.2-p15 amplification involving REL and XPO1 (6.3% vs 60.0%, P = .005), 3q23-q24 amplification (0.0% vs 50.0%, P = .004), 6q16.1-q23.3 deletion (6.3% vs 50.0%, P = .018), and 9p21.3 deletion covering CDKN2A and CDKN2B loci (0.0% vs 40.0%, P = .014, all Fisher exact test) in PCFCL. Analysis of sequential tumor samples in 2 cases harboring an unfavorable clinical course pointed to the acquisition of 2p amplification in the earliest common progenitor underlining its pivotal role in malignant transformation. By performing genome-wide copy number profiling on the largest patient cohort to date, we identified distinctive CNA alterations conceivably facilitating the differential diagnosis of PCFCL and secondary cutaneous involvement of nFL and potentially aiding the risk stratification of patients with PCFCL in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- HCEMM-SU Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary; Department of Internal Medicine and Hematology, Semmelweis University…
- HCEMM-SU Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
- Genomics and Evolutionary Dynamics Team, Centre for Evolution and Cancer, The Institute for Cancer Research, London, United Kingdom.
- HCEMM-SU Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary; Department of Biochemistry and Molecular Biology, Faculty of Medicine…
- Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
- Department of Dermatology, Venereology and Dermatooncology, Semmelweis University, Budapest, Hungary.
Förderung
- Wellcome Trust
- Semmelweis Egyetem
- European Union
- Magyar Tudományos Akadémia
- National Research, Development and Innovation Office
- National Research Development and Innovation Office
- Nemzeti Kutatási Fejlesztési és Innovációs Hivatal
- Egészségügyi Tudományos Tanács
Zitieren
APA
Bátai, B., Kiss, L., Varga, L., Nagy, Á., Househam, J., Baker, A. M., László, T., Udvari, A., Horváth, R., Nagy, T., Csomor, J., Szakonyi, J., Schneider, T., Graham, T. A., Alpár, D., Fitzgibbon, J., Szepesi, Á., & Bödör, C. (2024). Profiling of Copy Number Alterations Using Low-Coverage Whole-Genome Sequencing Informs Differential Diagnosis and Prognosis in Primary Cutaneous Follicle Center Lymphoma. Modern Pathology, 37(5), 100465. https://doi.org/10.1016/j.modpat.2024.100465
Vancouver
Bátai B, Kiss L, Varga L, Nagy Á, Househam J, Baker AM, et al. Profiling of Copy Number Alterations Using Low-Coverage Whole-Genome Sequencing Informs Differential Diagnosis and Prognosis in Primary Cutaneous Follicle Center Lymphoma. Modern Pathology. 2024;37(5):100465. doi:10.1016/j.modpat.2024.100465
BibTeX
@article{Btai2024,
author = {Bátai, Bence and Kiss, Laura and Varga, Luca and Nagy, Ákos and Househam, Jacob and Baker, Ann-Marie and László, Tamás and Udvari, Anna and Horváth, Róbert and Nagy, Tibor and Csomor, Judit and Szakonyi, József and Schneider, Tamás and Graham, Trevor A and Alpár, Donát and Fitzgibbon, Jude and Szepesi, Ágota and Bödör, Csaba},
title = {Profiling of Copy Number Alterations Using Low-Coverage Whole-Genome Sequencing Informs Differential Diagnosis and Prognosis in Primary Cutaneous Follicle Center Lymphoma},
journal = {Modern Pathology},
year = {2024},
volume = {37},
number = {5},
pages = {100465},
doi = {10.1016/j.modpat.2024.100465}
}
EUVIMED